Cargando…

Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection

BACKGROUND: The COVID-19 pandemic brings great pressure to the public health systems. This meta-analysis aimed to compare the clinical outcomes among different virus variants, to clarify their impact on medical resources and to provide evidence for the formulation of epidemic prevention policies. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanhua, Pan, Yuchen, Su, Kaisheng, Zhang, Yangyu, Jia, Zhifang, Yi, Jiaxin, Lv, Haiyong, Zhang, Lihuan, Xue, Mingyang, Cao, Donghui, Jiang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140352/
https://www.ncbi.nlm.nih.gov/pubmed/37125157
http://dx.doi.org/10.3389/fmicb.2023.1051104
_version_ 1785033140473954304
author Wu, Yanhua
Pan, Yuchen
Su, Kaisheng
Zhang, Yangyu
Jia, Zhifang
Yi, Jiaxin
Lv, Haiyong
Zhang, Lihuan
Xue, Mingyang
Cao, Donghui
Jiang, Jing
author_facet Wu, Yanhua
Pan, Yuchen
Su, Kaisheng
Zhang, Yangyu
Jia, Zhifang
Yi, Jiaxin
Lv, Haiyong
Zhang, Lihuan
Xue, Mingyang
Cao, Donghui
Jiang, Jing
author_sort Wu, Yanhua
collection PubMed
description BACKGROUND: The COVID-19 pandemic brings great pressure to the public health systems. This meta-analysis aimed to compare the clinical outcomes among different virus variants, to clarify their impact on medical resources and to provide evidence for the formulation of epidemic prevention policies. METHODS: A systematic literature search was performed in the PubMed, Embase, and Cochrane Library databases using the key words “Omicron” and “Delta.” The adjusted Risk ratios (RRs), Odds ratios (ORs) and Hazard ratios (HRs) were extracted, and RRs and Rate difference % (RD%) were used to interpret the risk estimates of the outcomes ultimately. RESULTS: Forty-three studies were included, with 3,812,681 and 14,926,841 individuals infected with SARS-CoV-2 Delta and Omicron variant, respectively. The relative risks of hospitalization, death, ICU admission, and mechanical ventilation use after infection with the Omicron variant were all significantly reduced compared those after infection with the Delta variant (RR(hospitalization) = 0.45, 95%CI: 0.40–0.52; RR(death) = 0.37, 95%CI: 0.30–0.45; RR(ICU) = 0.35, 95%CI: 0.29–0.42; RR(mechanical ventilation) = 0.33, 95%CI: 0.25–0.44). The change of both absolute and relative risks for hospitalization was more evident (RR = 0.47, 95%CI: 0.42–0.53;RD% =10.61, 95%CI: 8.64–12.59) and a significant increase was observed for the absolute differences in death in the elderly (RD% = 5.60, 95CI%: 4.65–6.55); the change of the absolute differences in the risk of hospitalization and death were most markedly observed in the patients with booster vaccination (RD%(hospitalization) = 8.60, 95CI%: 5.95–11.24; RD%(death) = 3.70, 95CI%: 0.34–7.06). CONCLUSION: The ability of the Omicron variant to cause severe clinical events has decreased significantly, as compared with the Delta variant, but vulnerable populations still need to be vigilant. There was no interaction between the vaccination doses and different variants.
format Online
Article
Text
id pubmed-10140352
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101403522023-04-29 Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection Wu, Yanhua Pan, Yuchen Su, Kaisheng Zhang, Yangyu Jia, Zhifang Yi, Jiaxin Lv, Haiyong Zhang, Lihuan Xue, Mingyang Cao, Donghui Jiang, Jing Front Microbiol Microbiology BACKGROUND: The COVID-19 pandemic brings great pressure to the public health systems. This meta-analysis aimed to compare the clinical outcomes among different virus variants, to clarify their impact on medical resources and to provide evidence for the formulation of epidemic prevention policies. METHODS: A systematic literature search was performed in the PubMed, Embase, and Cochrane Library databases using the key words “Omicron” and “Delta.” The adjusted Risk ratios (RRs), Odds ratios (ORs) and Hazard ratios (HRs) were extracted, and RRs and Rate difference % (RD%) were used to interpret the risk estimates of the outcomes ultimately. RESULTS: Forty-three studies were included, with 3,812,681 and 14,926,841 individuals infected with SARS-CoV-2 Delta and Omicron variant, respectively. The relative risks of hospitalization, death, ICU admission, and mechanical ventilation use after infection with the Omicron variant were all significantly reduced compared those after infection with the Delta variant (RR(hospitalization) = 0.45, 95%CI: 0.40–0.52; RR(death) = 0.37, 95%CI: 0.30–0.45; RR(ICU) = 0.35, 95%CI: 0.29–0.42; RR(mechanical ventilation) = 0.33, 95%CI: 0.25–0.44). The change of both absolute and relative risks for hospitalization was more evident (RR = 0.47, 95%CI: 0.42–0.53;RD% =10.61, 95%CI: 8.64–12.59) and a significant increase was observed for the absolute differences in death in the elderly (RD% = 5.60, 95CI%: 4.65–6.55); the change of the absolute differences in the risk of hospitalization and death were most markedly observed in the patients with booster vaccination (RD%(hospitalization) = 8.60, 95CI%: 5.95–11.24; RD%(death) = 3.70, 95CI%: 0.34–7.06). CONCLUSION: The ability of the Omicron variant to cause severe clinical events has decreased significantly, as compared with the Delta variant, but vulnerable populations still need to be vigilant. There was no interaction between the vaccination doses and different variants. Frontiers Media S.A. 2023-04-14 /pmc/articles/PMC10140352/ /pubmed/37125157 http://dx.doi.org/10.3389/fmicb.2023.1051104 Text en Copyright © 2023 Wu, Pan, Su, Zhang, Jia, Yi, Lv, Zhang, Xue, Cao and Jiang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Wu, Yanhua
Pan, Yuchen
Su, Kaisheng
Zhang, Yangyu
Jia, Zhifang
Yi, Jiaxin
Lv, Haiyong
Zhang, Lihuan
Xue, Mingyang
Cao, Donghui
Jiang, Jing
Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
title Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
title_full Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
title_fullStr Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
title_full_unstemmed Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
title_short Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
title_sort elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of omicron and delta variant: a meta-analysis of sars-cov-2 infection
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140352/
https://www.ncbi.nlm.nih.gov/pubmed/37125157
http://dx.doi.org/10.3389/fmicb.2023.1051104
work_keys_str_mv AT wuyanhua elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT panyuchen elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT sukaisheng elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT zhangyangyu elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT jiazhifang elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT yijiaxin elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT lvhaiyong elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT zhanglihuan elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT xuemingyang elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT caodonghui elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection
AT jiangjing elderandboostervaccinationassociateswithdecreasedriskofseriousclinicaloutcomesincomparisonofomicronanddeltavariantametaanalysisofsarscov2infection